Swiss National Bank Crispr Therapeutics Ag Transaction History

Swiss National Bank

$150 Billion
Q3 2024

A detailed history of Swiss National Bank transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Swiss National Bank holds 157,600 shares of CRSP stock, worth $7.55 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

157,600

Previous 158,700 0.69%

Holding current value

$7.55 Million

Previous $8.57 Million 13.6%

% of portfolio

0.0%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$44.62 - $62.75 $49,082 - $69,025	-1,100 Reduced 0.69%	157,600 $7.41 Million
Q2 2024 Aug 08, 2024	BUY	$51.17 - $68.18 $501,466 - $668,164	9,800 Added 6.58%	158,700 $8.57 Million
Q1 2024 May 07, 2024	BUY	$60.67 - $89.12 $12,134 - $17,824	200 Added 0.13%	148,900 $10.1 Million
Q4 2023 Feb 06, 2024	SELL	$38.62 - $72.18 $621,782 - $1.16 Million	-16,100 Reduced 9.77%	148,700 $9.31 Million
Q3 2023 Nov 08, 2023	BUY	$45.39 - $59.0 $95,319 - $123,900	2,100 Added 1.29%	164,800 $7.48 Million
Q2 2023 Aug 09, 2023	BUY	$43.47 - $67.77 $95,634 - $149,094	2,200 Added 1.37%	162,700 $9.13 Million
Q1 2023 May 10, 2023	SELL	$41.0 - $56.12 $758,500 - $1.04 Million	-18,500 Reduced 10.34%	160,500 $7.26 Million
Q4 2022 Feb 08, 2023	BUY	$39.19 - $65.67 $176,355 - $295,515	4,500 Added 2.58%	179,000 $7.28 Million
Q3 2022 Nov 09, 2022	BUY	$61.1 - $83.78 $103,870 - $142,426	1,700 Added 0.98%	174,500 $11.4 Million
Q2 2022 Aug 09, 2022	BUY	$43.23 - $73.83 $1.21 Million - $2.07 Million	28,100 Added 19.42%	172,800 $10.5 Million
Q1 2022 May 09, 2022	BUY	$53.19 - $79.24 $569,133 - $847,868	10,700 Added 7.99%	144,700 $9.08 Million
Q3 2021 Nov 08, 2021	BUY	$110.2 - $156.64 $110,200 - $156,640	1,000 Added 0.75%	134,000 $15 Million
Q2 2021 Aug 06, 2021	SELL	$100.84 - $161.89 $211,764 - $339,969	-2,100 Reduced 1.55%	133,000 $21.5 Million
Q1 2021 May 07, 2021	BUY	$110.72 - $210.04 $1.78 Million - $3.38 Million	16,100 Added 13.53%	135,100 $16.5 Million
Q4 2020 Feb 05, 2021	BUY	$79.67 - $173.23 $215,109 - $467,721	2,700 Added 2.32%	119,000 $18.2 Million
Q3 2020 Nov 09, 2020	BUY	$78.5 - $100.64 $2.2 Million - $2.82 Million	28,000 Added 31.71%	116,300 $9.73 Million
Q2 2020 Aug 05, 2020	BUY	$38.5 - $76.05 $1.16 Million - $2.28 Million	30,000 Added 51.46%	88,300 $6.49 Million
Q1 2020 May 08, 2020	BUY	$33.68 - $62.53 $202,080 - $375,180	6,000 Added 11.47%	58,300 $2.47 Million
Q4 2019 Feb 06, 2020	BUY	$36.68 - $73.13 $102,704 - $204,764	2,800 Added 5.66%	52,300 $3.19 Million
Q3 2019 Nov 12, 2019	BUY	$40.99 - $52.56 $36,891 - $47,304	900 Added 1.85%	49,500 $2.03 Million
Q2 2019 Aug 02, 2019	BUY	$35.45 - $48.2 $382,860 - $520,560	10,800 Added 28.57%	48,600 $2.29 Million
Q1 2019 May 10, 2019	BUY	$28.02 - $40.87 $112,080 - $163,480	4,000 Added 11.83%	37,800 $1.35 Million
Q3 2018 Nov 08, 2018	BUY	$44.35 - $65.71 $44,350 - $65,710	1,000 Added 3.05%	33,800 $1.5 Million
Q2 2018 Aug 09, 2018	BUY	$42.62 - $73.59 $1.4 Million - $2.41 Million	32,800 New	32,800 $1.93 Million

Others Institutions Holding CRSP

# of Institutions

491

Shares Held

58M

Call Options Held

1.1M

Put Options Held

1.9M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.74B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Crispr Therapeutics Ag Transaction History